Breakthrough Drug for Covid-19 May Be Risky for Mild Cases

By BY RONI CARYN RABIN from NYT Health https://www.nytimes.com/2020/06/24/health/coronavirus-dexamethasone.html?partner=IFTTT
via Maxma Group